Equities
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)14.39
  • Today's Change-0.41 / -2.77%
  • Shares traded284.16k
  • 1 Year change-6.74%
  • Beta0.6552
Data delayed at least 20 minutes, as of Sep 20 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of AUD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue968266
OPERATING EXPENSES
Cost of revenue total(1.11)(7.69)1.35
Selling, general and admin. expenses, total363926
Depreciation/amortization1.140.790.76
Unusual expense(income)1.181.300.93
Other operating expenses, total------
Total operating expense403430
Operating income564836
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes514634
Provision for income taxes151513
Net income after taxes363121
Minority interest------
Net income before extra. Items363121
Total extraordinary items------
Net income363121
Inc.avail. to common excl. extra. Items363121
Inc.avail. to common incl. extra. Items363121
EPS RECONCILIATION
Basic/primary weighted average shares504949
Basic/primary eps excl. extra items0.720.620.42
Basic/primary eps incl. extra items0.720.620.42
Dilution adjustment------
Diluted weighted average shares515252
Diluted eps excl. extra items0.700.590.40
Diluted eps incl. extra items0.700.590.40
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.050.050.04
Gross dividend - common stock02.471.98
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental------
SUPPLEMENTAL INCOME
Depreciation, supplemental1.140.790.76
Total special items1.181.300.90
NORMALISED INCOME
Normalized income before taxes524735
Effect of special items on income taxes0.350.430.35
Income tax excluding impact of special items151514
Normalized income after tax363121
Normalized income avail. to common363121
Basic normalized EPS0.730.640.43
Diluted normalized EPS0.710.610.41
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.